SIS
NKTR icon

Strategic Investment Solutions’s Nektar Therapeutics NKTR Stock Holding History

Strategic Investment Solutions’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$113 Sell
13
-827
-98% -$6.26K ﹤0.01% 1089
2023
Q3 		$8.09K Buy
840
+827
+6,362% +$7.96K ﹤0.01% 668
2023
Q2 		$120 Hold
13
– – ﹤0.01% 843
2023
Q1 		$141 Buy
+13
New +$393 ﹤0.01% 984

Other funds holding NKTR

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Strategic Investment Solutions's NKTR Position: Q4 2023 in Review

Strategic Investment Solutions reduced its Nektar Therapeutics (NKTR) stake by 98% in Q4 2023, selling an estimated $6.26K and leaving 13 shares worth $113. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

Strategic Investment Solutions first reported a position in NKTR in Q1 2023 and has held it in 4 quarters since. The position peaked at $8.09K in Q3 2023. 125 funds tracked by Wall St. Rank hold NKTR as of Q4 2023.

  • Strategic Investment Solutions held 13 shares of Nektar Therapeutics worth $113 as of Q4 2023.
  • Strategic Investment Solutions sold 827 Nektar Therapeutics shares in Q4 2023, an estimated $6.26K.
  • Nektar Therapeutics made up ﹤0.01% of Strategic Investment Solutions's portfolio in Q4 2023, its #1089 holding.
  • Strategic Investment Solutions first reported a position in Nektar Therapeutics in Q1 2023 and has held it in 4 quarters since.
  • Strategic Investment Solutions's Nektar Therapeutics position peaked at $8.09K in Q3 2023.
  • 125 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2023.

Based on Strategic Investment Solutions's 13F filing for Q4 2023, filed 13 Feb 2024.